Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation

OBJECTIVES: Despite advances in screening and prevention, rates of premature coronary artery disease (CAD) have been stagnant. The goals of this study were to investigate the barriers to early risk detection and preventive treatment in patients with premature CAD. In particular, we: 1) assessed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Vikulova, Diana N., Skorniakov, Ilia S., Bitoiu, Brendon, Brown, Chad, Theberge, Emilie, Fordyce, Christopher B., Francis, Gordon A., Humphries, Karin H., Mancini, G.B. John, Pimstone, Simon N., Brunham, Liam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315606/
https://www.ncbi.nlm.nih.gov/pubmed/34327459
http://dx.doi.org/10.1016/j.ajpc.2020.100036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315606/
https://www.ncbi.nlm.nih.gov/pubmed/34327459
http://dx.doi.org/10.1016/j.ajpc.2020.100036

Ejemplares similares